Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
MK-2894
Cat No.
CEI-1426
Description
MK-2894 is a highly potent and selective inhibitor of EP4 receptor with IC50 value of 2.5 nM.
Product Overview
MK-2894 is a highly potent and selective inhibitor of EP4 receptor with IC50 value of 2.5 nM. MK-2894 is a highly selective and potent second generation EP4 antagonist with a Ki of 0.56±0.1nM in the radio ligand binding assay using membranes prepared from human EP1-4 overexpressed HEK 293 cell lines. And the EP4 functional assay measures the inhibition of PGE2-induced cAMP accumulation with IC50 of 2.5±0.7nM. In the AIA model and GI tolerability model in male SD rats, MK-2894 shows a dose-dependent inhibition of pain response with ED50 of 0.36 mg/kg. It also has the potent activity in inhibiting chronic pawswelling with ED50 of 0.02 mg/kg/day. Overall, MK-2894 displays the desired potency, selectivity, pharmacokinetic, and GI tolerability profile for further development and represents a potential safer alternative for treating pain and inflammation than traditional NSAIDs and coxibs.
CAS No.
1006036-87-8
Molecular Weight
473.51
Purity
0.98
Storage
Store at -20°C
Synonyms
MK 2894; MK2894
Targets
EP4 receptor
IC50
2.5 nM (Ki=0.56±0.1 nM）;
Molecular Formula
C25H22F3NO3S
Chemical Name
4-[1-[[2,5-dimethyl-4-[[4-(trifluoromethyl)phenyl]methyl]thiophene-3-carbonyl]amino]cyclopropyl]benzoic acid
Solubility
Soluble in DMSO
Shipping Conditions
Evaluation sample solution: ship with blue ice. All other available size: ship with RT, or blue ice upon request
Download
Download Datasheet